🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Does surgery spread lung cancer cells into the circulation? Probably, although clinical significance remains TBD. But a simple step can help prevent it. From AATS Journals #lcsm clinicalkey.com/#!/content/pla… In reference to clinicalkey.com/#!/content/pla…

Marie Skłodowska Curie defended her doctoral thesis on radioactive substances at Université de la Sorbonne in Paris on 25 June 1903 and became the first woman in France to receive a doctoral degree.

Honored and humbled to accept a new role as Division Chief for Hematology & Oncology at Georgetown starting next month. Excited for all that the future holds for Georgetown University Georgetown Lombardi with the best colleagues one could ask for.

Cell & Gene Therapies: THE LOGISTICS youtu.be/-sIfnkj0VAU?si… via YouTube Joe DePinto President of InspiroGene by McKesson Corporation joined #HealthcareUnfiltered this week to give behind the scenes look on what it takes to bring these expensive Tx to the patients that need them most.

Understand this: The world wants to assign you a role in life. And once you accept that role you are doomed.

AI vs. 𝕏 OncoBuzz: Top 10 GI Cancer Trials Presented At ESMO - Eur. Oncology Gastrointestinal (GI) Cancers Congress 2025 We asked three AI models to identify the top 10 GI cancer trials presented at ESMO GI 2025 and compared them with 𝕏 OncoBuzz. Key findings: - TALENTACE (TACE +

ONCO BRUNO Razelle Kurzrock, MD One of the four FDA approved Aurostatin (MLAE) ADCs in the US. It carries a box warning. Toxicity is still relatively unpredictable. Antibody-Linker instability is around 50%

It was a pleasure collaborating with Dr. Mina Nikanjam and Dr. Razelle Kurzrock (Razelle Kurzrock, MD) on our recent Cancer Letters paper exploring Nectin-4 as a biomarker and therapeutic target. Read the full study here: sciencedirect.com/science/articl… #Larvol #PrecisionMedicine #Biomarkers

🟣 Most active cancer institutes on X in Q2 2025, based on oncologists' posts and views. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #ClinicalTrials #OncologyInsights #CancerData

prof. Nicolas Girard gave me a tour of Marie Curie’s lab (still radioactive) today !!

Adjuvant Chemoradiation & Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer JAMA Oncology doi.org/10.1001/jamaon… 🔎🇨🇳phs-2 trial 👉Camrelizumab > cape + RT vs obs. 👉3-year OS rate: 58.2 vs 30.5% 🧐Supports adj. Tx, ARTEMIDE-Biliary01 awaited ESMO - Eur. Oncology EASL Education

With 3 HER2 TKIs approved for HER2+ MBC (and more coming), should we consider sequencing them? Interesting real world study including 24 pts with sequential TKI: 58% of patients with sequential TKI stayed on the second for >6 months, 38% for >1 year. clinical-breast-cancer.com/article/S1526-…

Back in San Francisco. #Squatanywhere

Thanks Reena Thakur for preparing this.

ONCO BRUNO 😊😍😍love it

Blenrep ODAC this week #mmsm

📉 Omitting the 5-FU bolus in GI cancers may reduce hematologic toxicity without compromising efficacy (PFS/OS), according to a meta-analysis of >12,000 patients 🔗 pubmed.ncbi.nlm.nih.gov/40590359/ Do you omit the 5-FU bolus in GI cancer? Grupo Español de Tratamiento de Tumores Digestivos ESMO - Eur. Oncology #ESMOGI25

Very important adjustment to FLAURA2 reimbursement in NHS England ; allowing early initiation of TKI while the chemo gets set up. Brilliant initiative by the cancer drugs fund team. BTOG #EGFR EGFR Positive Lung Cancer UK

Thank you to all my connections. Especially oncologists. I appreciate your support and our interactions. Looking forward to seeing many of you at #WCLC25 and #ESMO25 .. look for the purple

Liberté